Filing metadata

Accession number
0001562180-19-005150
Form type
Form 4
Filer
EyePoint Pharmaceuticals, Inc.
CIK
CIK 1314102
Filed
Oct 11, 2019
Reporting period
Oct 09, 2019
Description
Insider transaction

Explore SEC Filings Hub